NASDAQ:NBIX

Neurocrine Biosciences Stock Insider Trading

etoro logo Buy NBIX
*Your capital is at risk
$165.11
+10.27 (+6.63%)
At Close: Jun 03, 2026

Neurocrine Biosciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -60.71. In total, the insiders bought 1M and sold 337.42K NBIX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-60.71
Buy 1M shares
Sell 337.42K shares
77% Buy Activity
Negligible or No Correlation
Sell Signal Medium Confidence
May 19, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -60.71.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 01, 2026
Buy
Non-Qualified Stock Option
M-Exempt
Onyia Jude
Chief Scientific Officer
Officer 11 000
Value: $932.1K
Jun 01, 2026
Buy
Common Stock
M-Exempt
Onyia Jude
Chief Scientific Officer
Officer 11 000
Value: $932.1K
Jun 01, 2026
Sell
Common Stock
S-Sale
Onyia Jude
Chief Scientific Officer
Officer 11 000
Value: $1.76M
May 29, 2026
Sell
Common Stock
S-Sale
Delaet Ingrid
Chief Regulatory Officer
Officer 2 261
Value: $354.3K
May 29, 2026
Buy
Common Stock
M-Exempt
Delaet Ingrid
Chief Regulatory Officer
Officer 2 261
Value: $178.7K
May 29, 2026
Buy
Non-Qualified Stock Option
M-Exempt
Delaet Ingrid
Chief Regulatory Officer
Officer 2 261
Value: $178.7K
May 27, 2026
Buy
Common Stock
M-Exempt
Onyia Jude
Chief Scientific Officer
Officer 11 000
Value: $932.1K
May 27, 2026
Sell
Common Stock
S-Sale
Onyia Jude
Chief Scientific Officer
Officer 11 000
Value: $1.71M
May 27, 2026
Buy
Restriced Stock Unit
A-Award
Poon Christine A
Director
Director 2 567
Value: $400.0K
May 27, 2026
Buy
Non-Qualified Stock Option
A-Award
Lyons Gary A
Director
Director 2 624
Value: $408.9K
May 27, 2026
Buy
Non-Qualified Stock Option
A-Award
Gorman Kevin Charles
Director
Director 5 248
Value: $817.8K
May 27, 2026
Buy
Restriced Stock Unit
A-Award
Sherwin Stephen A
Director
Director 2 567
Value: $400.0K
May 27, 2026
Buy
Restriced Stock Unit
A-Award
Norwalk Leslie V
Director
Director 1 284
Value: $200.1K
May 27, 2026
Buy
Restriced Stock Unit
A-Award
Rastetter William H
Director
Director 2 567
Value: $400.0K
May 27, 2026
Buy
Non-Qualified Stock Option
A-Award
Norwalk Leslie V
Director
Director 2 624
Value: $408.9K
May 27, 2026
Buy
Restriced Stock Unit
A-Award
Sharp Shalini
Director
Director 2 567
Value: $400.0K
May 27, 2026
Buy
Restriced Stock Unit
A-Award
Morrow George J
Director
Director 2 567
Value: $400.0K
May 27, 2026
Buy
Restriced Stock Unit
A-Award
Pops Richard F
Director
Director 2 567
Value: $400.0K
May 27, 2026
Buy
Restriced Stock Unit
A-Award
Lyons Gary A
Director
Director 1 284
Value: $200.1K
May 27, 2026
Buy
Restriced Stock Unit
A-Award
Mercier Johanna
Director
Director 2 567
Value: $400.0K
May 27, 2026
Buy
Non-Qualified Stock Option
M-Exempt
Onyia Jude
Chief Scientific Officer
Officer 11 000
Value: $932.1K
May 26, 2026
Sell
Common Stock
S-Sale
Boyer David W.
Chief Corp. Affairs Officer
Officer 3 888
Value: $609.0K
May 21, 2026
Buy
Common Stock
M-Exempt
Morrow George J
Director
Director 3 318
Value: $515.9K
May 21, 2026
Buy
Common Stock
M-Exempt
Norwalk Leslie V
Director
Director 1 659
Value: $258.0K
May 21, 2026
Buy
Common Stock
M-Exempt
Poon Christine A
Director
Director 3 318
Value: $515.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT NEUROCRINE BIOSCIENCES
Neurocrine Biosciences
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products include ON...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE